JT
Jameela Thayyil Kizhakkethil
About Jameela Thayyil Kizhakkethil
Data last updated:
Jameela Thayyil Kizhakkethil is a Director at Orient Drugs Private Limited (since 1997). The company operates in Pharma. Orient Drugs Private Limited reported revenue of ₹7.95 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Sep 1997 | 1997 | ₹7.95 Cr (FY 2025) | Active |
Board colleagues of Jameela Thayyil Kizhakkethil
| Name | DIN | Company | Designation |
|---|---|---|---|
| Abdu Avulan | 01827943 | Orient Drugs Private Limited | Managing Director |
| Fathima Sheikmoossa Avulan | 07460057 | Orient Drugs Private Limited | Director |
| Favas Avulan | 06759875 | Orient Drugs Private Limited | Director |
| Mumtaz Pothaparambath | 07460080 | Orient Drugs Private Limited | Director |
| Naseer Kalappaden | 01827936 | Orient Drugs Private Limited | Director |
| Shibibiyya Mecheri | 09568099 | Orient Drugs Private Limited | Director |
| Ummer Thekkepath | 07463474 | Orient Drugs Private Limited | Director |
| Zubairali Valiyathodi | 07460101 | Orient Drugs Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jameela Thayyil Kizhakkethil
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jameela Thayyil Kizhakkethil
Jameela Thayyil Kizhakkethil currently holds 1 directorship: Orient Drugs Private Limited (Director, since 01 Sep 1997, revenue ₹7.95 Cr (FY 2025)).
Jameela Thayyil Kizhakkethil was first appointed on 01 Sep 1997 as Director at Orient Drugs Private Limited.
The current boards of Jameela Thayyil Kizhakkethil's companies include Abdu Avulan (Orient Drugs Private Limited), Fathima Sheikmoossa Avulan (Orient Drugs Private Limited), Favas Avulan (Orient Drugs Private Limited), Mumtaz Pothaparambath (Orient Drugs Private Limited), Naseer Kalappaden (Orient Drugs Private Limited), Shibibiyya Mecheri (Orient Drugs Private Limited), among others.